Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis

Bibliographic Details
Main Authors:	Pavani Reddy, John P. Flaherty
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2006-11-01
Series:	Emerging Infectious Diseases
Subjects:	Plasmodium vivax primaquine failure relapse resistance letter
Online Access:	https://wwwnc.cdc.gov/eid/article/12/11/06-0613_article

Similar Items

Relapse of imported <it>Plasmodium vivax</it> malaria is related to primaquine dose: a retrospective study
by: Townell Nicola, et al.
Published: (2012-06-01)

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
by: Chamnanphon M, et al.
Published: (2020-01-01)

Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria
by: A. Taylor Bright, et al.
Published: (2013-05-01)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
by: Ebstie YA, et al.
Published: (2016-07-01)

Safety of weekly primaquine in G6PD deficient patient with relapsing vivax malaria: A case report
by: Deepali Savargaonkar, et al.
Published: (2017-01-01)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
by: Agus Setyadi, et al.
Published: (2019-04-01)

Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
by: Audrey Valdes, et al.
Published: (2018-06-01)

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function
by: Alexandra Martin Ramírez, et al.
Published: (2020-07-01)

Primaquine in vivax malaria: an update and review on management issues
by: Fernando Deepika, et al.
Published: (2011-12-01)

Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases
by: Anielle de Pina-Costa, et al.
Published: (2021-08-01)

The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
by: Koukeo Phommasone, et al.
Published: (2020-01-01)

A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India
by: Kavitha Saravu, et al.
Published: (2018-09-01)

Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon
by: Wilson M Ramos Júnior, et al.

Subdoses of primaquine in overweight patients and malaria vivax relapses: report of two cases in the Federal District, Brazil Subdoses de primaquina associadas a recaídas de malária vivax em pacientes com peso elevado: relato de dois casos no Distrito Federal
by: João Barberino Santos, et al.
Published: (2010-12-01)

Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report
by: Xi He, et al.
Published: (2019-08-01)

Evaluation of Plasmodium vivax malaria recurrence in Brazil
by: André Daher, et al.
Published: (2019-01-01)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
by: J. Kevin Baird, et al.
Published: (2018-01-01)

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
by: Robert J. Commons, et al.
Published: (2019-08-01)

Severe Plasmodium vivax Malaria, Brazilian Amazon
by: Márcia A. Alexandre, et al.
Published: (2010-10-01)

Recurrencias de malaria por Plasmodium vivax según el uso de primaquina: análisis de estudios descriptivos longitudinales Plasmodium vivax malaria recurrence according to the use of primaquine: analysis of longitudinal descriptive studies
by: Jaime Carmona-Fonseca
Published: (2012-09-01)

The changing behaviour of Plasmodium vivax in Colombia relapses despite standard treatment with primaquine
by: Rubén Santiago Nicholls, et al.
Published: (1994-01-01)

Exploration of Plasmodium vivax transmission dynamics and recurrent infections in the Peruvian Amazon using whole genome sequencing
by: Annie N. Cowell, et al.
Published: (2018-07-01)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
by: Walter Robert Taylor, et al.
Published: (2021-09-01)

Validade interna de ensaios terapêuticos em malária: análise de estudos de avaliação da emergência de resistência in vivo do Plasmodium vivax a doses padronizadas de primaquina Internal validity of clinical trials for Plasmodium vivax malaria treatment
by: Elisabeth Carmen Duarte, et al.
Published: (2003-06-01)

Management of Plasmodium vivax risk and illness in travelers
by: J. Kevin Baird
Published: (2017-03-01)

A clinical tool to predict Plasmodium vivax recurrence in Malaysia
by: Norliza Mat Ariffin, et al.
Published: (2017-12-01)

On the epidemiology of Plasmodium vivax malaria: past and present with special reference to the former USSR
by: Anatoly V. Kondrashin, et al.
Published: (2018-10-01)

Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
by: Francisco Javier López-Antuñano
Published: (1999-10-01)

Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses
by: Michael T. White, et al.
Published: (2018-04-01)

CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region
by: Paula Ferreira Salles, et al.
Published: (2021-07-01)

<it>Plasmodium vivax</it> malaria relapses at a travel medicine centre in Rio de Janeiro, a non-endemic area in Brazil
by: Pedro Renata S, et al.
Published: (2012-07-01)

Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
by: Mac Donald-Ottevanger MS, et al.
Published: (2017-12-01)

Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes
by: Sarunya Maneerattanasak, et al.
Published: (2017-05-01)

Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
by: López-Antuñano Francisco Javier
Published: (1999-01-01)

The association of CYP2D6 gene polymorphisms in the full-length coding region with higher recurrence rate of vivax malaria in Yunnan Province, China
by: Herong Huang, et al.
Published: (2021-03-01)

Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions
by: Marcelo U. Ferreira, et al.
Published: (2021-04-01)

Concurrent Plasmodium vivax Malaria and Dengue
by: Stan Deresinski
Published: (2006-11-01)

Complicated congenital malaria due to Plasmodium vivax
by: Angélica María Díaz-Contreras, et al.
Published: (2015-07-01)

Plasmodium vivax severe imported malaria in two migrants in France
by: Arezki Izri, et al.
Published: (2019-12-01)

Correlation between Plasmodium vivax variants in Belém, Pará State, Brazil and symptoms and clearance of parasitaemia
by: Machado Ricardo Luiz Dantas, et al.
Published: (2003-01-01)